# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HC Wainwright & Co. analyst Edward White reiterates Curis (NASDAQ:CRIS) with a Buy and maintains $26 price target.
Curis (NASDAQ:CRIS) reported quarterly losses of $(2.05) per share which beat the analyst consensus estimate of $(2.12) by 3.3 ...
As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum a...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...
HC Wainwright & Co. analyst Edward White maintains Curis (NASDAQ:CRIS) with a Buy and lowers the price target from $51 t...
-S-3
Curis (NASDAQ:CRIS) reported quarterly losses of $(2.03) per share which beat the analyst consensus estimate of $(2.11) by 3.79...